ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 706,89
0,00%
Dow Jones
39 411,21
0,67%
DAX
18 342,83
0,00%
Brent Oil
85,115
-0,18%
Bitcoin
61 106,63
1,39%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. AQSE
  6. Immupharma Plc (IMM.GB)

  7. Immupharma Plc (IMM.GB) Actualités

IMM.GB

Immupharma (IMM.GB)

Immupharma Plc
De:
Trier par:
 Showing the most relevant articles for your search:AQSE:IMM.GB
DateHeureSourceTitreSymboleSociété
28/12/202314h35UK RegulatoryImmupharma PLC Holding(s) in CompanyAQSE:IMM.GBImmupharma Plc
19/12/202308h00UK RegulatoryImmupharma PLC Simbec-Orion appointed as CROAQSE:IMM.GBImmupharma Plc
18/12/202308h15UK RegulatoryImmupharma PLC Incanthera - Comm'l Skincare Deal/GBP1M FundraiseAQSE:IMM.GBImmupharma Plc
07/09/202308h00UK RegulatoryImmupharma PLC Result of Retail Offer and Director ShareholdingAQSE:IMM.GBImmupharma Plc
31/08/202308h02UK RegulatoryImmupharma PLC WRAP Retail Offer for up to GBP0.5mAQSE:IMM.GBImmupharma Plc
31/08/202308h01UK RegulatoryImmupharma PLC Subscription to raise GBP1.35m; Sharing Agr, RPTAQSE:IMM.GBImmupharma Plc
31/08/202308h00UK RegulatoryImmupharma PLC Interim resultsAQSE:IMM.GBImmupharma Plc
21/08/202308h00UK RegulatoryImmupharma PLC Extension of warrants in Incanthera plcAQSE:IMM.GBImmupharma Plc
11/08/202313h04UK RegulatoryImmupharma PLC Directorate ChangeAQSE:IMM.GBImmupharma Plc
30/06/202314h12UK RegulatoryImmupharma PLC Result of AGMAQSE:IMM.GBImmupharma Plc
19/06/202308h00UK RegulatoryImmupharma PLC Lupuzor UpdateAQSE:IMM.GBImmupharma Plc
06/06/202308h00UK RegulatoryImmupharma PLC IMM RNS Posting of RA and Notice of AGM 30 June 23AQSE:IMM.GBImmupharma Plc
18/05/202308h00UK RegulatoryImmupharma PLC Positive Pre-IND meeting with FDAAQSE:IMM.GBImmupharma Plc
11/05/202308h00UK RegulatoryImmupharma PLC Final ResultsAQSE:IMM.GBImmupharma Plc
19/04/202308h00UK RegulatoryImmupharma PLC Lupozor Update - FDA confirms Type-C meeting dateAQSE:IMM.GBImmupharma Plc
12/04/202308h00UK RegulatoryImmupharma PLC CIDP P140 Clinical Program UpdateAQSE:IMM.GBImmupharma Plc
27/03/202308h00UK RegulatoryImmupharma PLC Lupuzor(TM) UpdateAQSE:IMM.GBImmupharma Plc
09/03/202317h35UK RegulatoryImmupharma PLC Price Monitoring ExtensionAQSE:IMM.GBImmupharma Plc
06/03/202308h00UK RegulatoryImmupharma PLC Collaboration with Orano on ImmuPharma PeptideAQSE:IMM.GBImmupharma Plc
27/01/202317h25UK RegulatoryImmupharma PLC TR-1: Notification of major holdingsAQSE:IMM.GBImmupharma Plc
04/01/202317h40UK RegulatoryImmupharma PLC Second Price Monitoring ExtnAQSE:IMM.GBImmupharma Plc
22/12/202208h55UK RegulatoryImmupharma PLC Grant of OptionsAQSE:IMM.GBImmupharma Plc
22/12/202208h00UK RegulatoryImmupharma PLC End of Year UpdateAQSE:IMM.GBImmupharma Plc
07/10/202217h44UK RegulatoryImmupharma PLC Company Secretary ChangeAQSE:IMM.GBImmupharma Plc
06/10/202218h17UK RegulatoryIncanthera PLC Holding(s) in CompanyAQSE:IMM.GBImmupharma Plc
30/09/202208h00UK RegulatoryImmupharma PLC Interim Results or the 6mths Ended 30 June 2022AQSE:IMM.GBImmupharma Plc
14/09/202211h04UK RegulatoryImmupharma PLC Written Response received from the FDAAQSE:IMM.GBImmupharma Plc
07/09/202209h25UK RegulatoryImmupharma PLC Exercise of OptionsAQSE:IMM.GBImmupharma Plc
31/08/202208h01UK RegulatoryImmupharma PLC FDA response for Type C Meeting - updateAQSE:IMM.GBImmupharma Plc
17/08/202219h12UK RegulatoryImmupharma PLC TR-1 Notification of major holdingsAQSE:IMM.GBImmupharma Plc
 Showing the most relevant articles for your search:AQSE:IMM.GB

Dernières Valeurs Consultées

NASDAQ
LNDC
Landec
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés